Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Tandem Diabetes Care (TNDM) over the last 7 years, with Q3 2025 value amounting to 1.46%.

  • Tandem Diabetes Care's Return on Invested Capital fell 9600.0% to 1.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.46%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 0.34% for FY2024, which is 2900.0% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Return on Invested Capital of 1.46% as of Q3 2025, which was down 9600.0% from 1.23% recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Return on Invested Capital registered a high of 0.08% during Q3 2021, and its lowest value of 1.46% during Q3 2025.
  • Over the past 5 years, Tandem Diabetes Care's median Return on Invested Capital value was 0.5% (recorded in 2024), while the average stood at 0.43%.
  • In the last 5 years, Tandem Diabetes Care's Return on Invested Capital soared by 3900bps in 2024 and then crashed by -9600bps in 2025.
  • Tandem Diabetes Care's Return on Invested Capital (Quarter) stood at 0.05% in 2021, then crashed by -510bps to 0.22% in 2022, then crashed by -242bps to 0.75% in 2023, then skyrocketed by 53bps to 0.36% in 2024, then crashed by -311bps to 1.46% in 2025.
  • Its last three reported values are 1.46% in Q3 2025, 1.23% for Q2 2025, and 0.75% during Q1 2025.